English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Anti-HER-3 MAbs inhibit HER-3-mediated signaling in breast cancer cell lines resistant to anti-HER-2 antibodies

van der Horst, E. H., Murgia, M., Treder, M., & Ullrich, A. (2005). Anti-HER-3 MAbs inhibit HER-3-mediated signaling in breast cancer cell lines resistant to anti-HER-2 antibodies. International Journal of Cancer, 115(4), 519-527.

Item is

Basic

show hide
Genre: Journal Article
Alternative Title : Int. J. Cancer

Files

show Files

Locators

show

Creators

show
hide
 Creators:
van der Horst, E. H.1, Author              
Murgia, M., Author
Treder, M.1, Author              
Ullrich, A.2, Author              
Affiliations:
1External Organizations, ou_persistent22              
2Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565172              

Content

show
hide
Free keywords: HER2; HER3; trastuzumab; breast cancer; antibody therapy
 Abstract: -

Details

show
hide
Language(s): eng - English
 Dates: 2005-07-01
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: eDoc: 255358
ISI: 000229082800003
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: International Journal of Cancer
  Alternative Title : Int. J. Cancer
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 115 (4) Sequence Number: - Start / End Page: 519 - 527 Identifier: ISSN: 0020-7136